Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- AI-powered care coordination and disease detection for stroke,pulmonary embolism,and aortic dissection
- Coverage: Global · Phase II–IV
- Therapeutic focus: Neurology, Cardiology, Radiology, Pulmonology
- Scale: Small,Medium
Company fit
Best suited for
Cardiovascular and neuroscience trials needing AI diagnostic triage
Study fit
Best suited for cardiovascular and neuroscience trials needing ai diagnostic triage.
Core strengths
- Real-time AI care coordination
- Stroke detection network
- FDA-cleared algorithms
Considerations
- AI/ML capabilities still maturing in clinical validation
Key facts
- Category
- AI / Machine Learning
- Geography
- Global
- Studies managed
- 20
- HQ
- United States
- Company size
- 100 employees
- Year founded
- 2016